Clinical trials
Phase 2/3 Triple Negative Breast Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2016 | 2 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 3 |
| Completed | 2 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| BeBetter Med Inc | 1 |
| Bristol-Myers Squibb | 1 |
| Cambridge University Hospitals NHS Foundation Trust | 1 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 1 |
| Celgene | 1 |
| ERYtech Pharma | 1 |
| Fudan University | 1 |
| Shanghai Jiaolian Drug Research and Development Co., Ltd | 1 |
| Tianjin Medical University Cancer Institute and Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Triple Negative Breast Neoplasms | 9 |
| Breast Neoplasms | 4 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.